FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Kimberly Kalli

Research Profile

Disorders

Anatomy

Chemicals & Drugs

Physiology

Living Beings

Mouse

Procedures

Devices

Oligonucleotide Array Sequence Analysis

Co-author Network

Publications

TOP 3
Michelle L Torres; Amy L Weaver; Phillip M Young; William A Cliby; Lynn C Hartmann; Aminah Jatoi; Kimberly R Kalli; Sanjeev Kumar; Carrie L Langstraat; Andrea Mariani
Nutritional status, CT body composition measures and survival in ovarian cancer.
Bridget Charbonneau; Ellen L Goode; Kimberly R Kalli; Keith L Knutson; Melissa S Derycke
The immune system in the pathogenesis of ovarian cancer.
Courtney L Erskine; KE Hedin; Sabrina M Heman-Ackah; Kimberly R Kalli; Christopher J Krco; Mansour Mohamadzadeh; Eric von Hofe; Peter J Wettstein; Marshall D Behrens; Nancy D Borson; Keith L Knutson
MHC class II epitope nesting modulates dendritic cell function and improves generation of antigen-specific CD4 helper T cells.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Kimberly Kalli (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Michelle L Torres; Amy L Weaver; Phillip M Young; William A Cliby; Lynn C Hartmann; Aminah Jatoi; Kimberly R Kalli; Sanjeev Kumar; Carrie L Langstraat; Andrea Mariani
Nutritional status, CT body composition measures and survival in ovarian cancer.
Gynecologic oncology 2013;129(3):548-53.
2013: Bridget Charbonneau; Ellen L Goode; Kimberly R Kalli; Keith L Knutson; Melissa S Derycke
The immune system in the pathogenesis of ovarian cancer.
Critical reviews in immunology 2013;33(2):137-64.
2011: Courtney L Erskine; KE Hedin; Sabrina M Heman-Ackah; Kimberly R Kalli; Christopher J Krco; Mansour Mohamadzadeh; Eric von Hofe; Peter J Wettstein; Marshall D Behrens; Nancy D Borson; Keith L Knutson
MHC class II epitope nesting modulates dendritic cell function and improves generation of antigen-specific CD4 helper T cells.
Journal of immunology (Baltimore, Md. : 1950) 2011;187(1):316-24.
2011: James Krempski; Marshall D Behrens; Haidong Dong; Courtney L Erskine; Ellen L Goode; Lynn Hartmann; Kimberly R Kalli; Lavakumar Karyampudi; Keith L Knutson
Tumor-infiltrating programmed death receptor-1+ dendritic cells mediate immune suppression in ovarian cancer.
Journal of immunology (Baltimore, Md. : 1950) 2011;186(12):6905-13.
2011: Kristin L White; David N Rider; Kimberly R Kalli; Keith L Knutson; Gail P Jarvik; Ellen L Goode
Genomics of the NF-κB signaling pathway: hypothesized role in ovarian cancer.
Cancer causes & control : CCC 2011;22(5):785-801.
2011: Claudia C Preston; Ellen L Goode; Lynn C Hartmann; Kimberly R Kalli; Keith L Knutson
Immunity and immune suppression in human ovarian cancer.
Immunotherapy 2011;3(4):539-56.
2011: Prema Peethambaram; David N Rider; Robert A Vierkant; Kristin L White; Julie M Cunningham; Elaine A Elliott; Brooke L Fridley; Lynn C Hartmann; Kimberly R Kalli; Gary L Keeney; Melissa C Larson; Ann L Oberg; Ellen L Goode
Polymorphisms in ABCB1 and ERCC2 associated with ovarian cancer outcome.
International journal of molecular epidemiology and genetics 2011;2(2):185-95.
2010: Kristin L White; Thomas A Sellers; Brooke L Fridley; Robert A Vierkant; Catherine M Phelan; Ya-Yu Tsai; Kimberly R Kalli; Andrew Berchuck; Edwin S Iversen; Lynn C Hartmann; Mark Liebow; Sebastian Armasu; Zachary Fredericksen; Melissa C Larson; David Duggan; Fergus J Couch; Joellen M Schildkraut; Julie M Cunningham; Ellen L Goode
Variation at 8q24 and 9p24 and risk of epithelial ovarian cancer.
Twin research and human genetics : the official journal of the International Society for Twin Studies 2010;13(1):43-56.
2010: Ellen L Goode; Matthew J Maurer; Thomas A Sellers; Catherine M Phelan; Kimberly R Kalli; Brooke L Fridley; Robert A Vierkant; Sebastian M Armasu; Kristin L White; Gary L Keeney; William A Cliby; David N Rider; Linda E Kelemen; Monica B Jones; Prema P Peethambaram; Johnathan M Lancaster; Janet E Olson; Joellen M Schildkraut; Julie M Cunningham; Lynn C Hartmann
Inherited determinants of ovarian cancer survival.
Clinical cancer research : an official journal of the American Association for Cancer Research 2010;16(3):995-1007.
2010: Lavakumar Karyampudi; Courtney Formicola; Courtney L Erskine; Matthew J Maurer; James N Ingle; Christopher J Krco; Peter J Wettstein; Kimberly R Kalli; John D Fikes; Melanie Beebe; Lynn C Hartmann; Mary L Disis; Soldano Ferrone; Glenn Ishioka; Keith L Knutson
A degenerate HLA-DR epitope pool of HER-2/neu reveals a novel in vivo immunodominant epitope, HER-2/neu88-102.
Clinical cancer research : an official journal of the American Association for Cancer Research 2010;16(3):825-34.
2010: Abraham Peedicayil; Robert A Vierkant; Lynn C Hartmann; Brooke L Fridley; Zachary S Fredericksen; Kristin L White; Elaine A Elliott; Catherine M Phelan; Ya-Yu Tsai; Andrew Berchuck; Edwin S Iversen; Fergus J Couch; Prema Peethamabaran; Melissa C Larson; Kimberly R Kalli; Matthew L Kosel; Viji Shridhar; David N Rider; Mark Liebow; Julie M Cunningham; Joellen M Schildkraut; Thomas A Sellers; Ellen L Goode
Risk of ovarian cancer and inherited variants in relapse-associated genes.
PloS one 2010;5(1):e8884.
2010: Lavakumar Karyampudi; Christopher J Krco; Kimberly R Kalli; Courtney L Erskine; Lynn C Hartmann; Karin Goodman; James N Ingle; Matthew J Maurer; Aziza Nassar; Chao Yu; Mary L Disis; Peter J Wettstein; John D Fikes; Melanie Beebe; Glenn Ishioka; Keith L Knutson
Identification of a broad coverage HLA-DR degenerate epitope pool derived from carcinoembryonic antigen.
Cancer immunology, immunotherapy : CII 2010;59(1):161-71.
2009: Marta Santisteban; Jennifer M Reiman; Michael K Asiedu; Marshall D Behrens; Aziza Nassar; Kimberly R Kalli; Paul Haluska; James N Ingle; Lynn C Hartmann; Masoud H Manjili; Derek Radisky; Soldano Ferrone; Keith L Knutson
Immune-induced epithelial to mesenchymal transition in vivo generates breast cancer stem cells.
Cancer research 2009;69(7):2887-95.
2009: Eati Basal; Guiti Z Eghbali-Fatourechi; Kimberly R Kalli; Lynn C Hartmann; Karin M Goodman; Ellen L Goode; Barton A. Kamen; Philip S Low; Keith L Knutson
Functional folate receptor alpha is elevated in the blood of ovarian cancer patients.
PloS one 2009;4(7):e6292.
2008: Elaine M Hurt; Jessica N Saykally; Bynthia M Anose; Kimberly R Kalli; Michel M Sanders
Expression of the ZEB1 (deltaEF1) transcription factor in human: additional insights.
Molecular and cellular biochemistry 2008;318(1-2):89-99.
2008: Wei He; Sumith A Kularatne; Kimberly R Kalli; Franklyn G Prendergast; Robert J Amato; George G Klee; Lynn C Hartmann; Philip S Low
Quantitation of circulating tumor cells in blood samples from ovarian and prostate cancer patients using tumor-specific fluorescent ligands.
International journal of cancer. Journal international du cancer 2008;123(8):1968-73.
2008: Kimberly R Kalli; Christopher J Krco; Lynn C Hartmann; Karin Goodman; Matthew J Maurer; Chao Yu; Elliot M Johnson; Courtney L Erskine; Mary L Disis; Peter J Wettstein; John D Fikes; Melanie Beebe; Glenn Ishioka; Keith L Knutson
An HLA-DR-degenerate epitope pool detects insulin-like growth factor binding protein 2-specific immunity in patients with cancer.
Cancer research 2008;68(12):4893-901.
2008: Kimberly R Kalli; Ann L Oberg; Gary L Keeney; Teresa J H Christianson; Philip S Low; Keith L Knutson; Lynn C Hartmann
Folate receptor alpha as a tumor target in epithelial ovarian cancer.
Gynecologic oncology 2008;108(3):619-26.
2008: Marshall Behrens; Wolfgang M Wagner; Christopher J Krco; Courtney L Erskine; Kimberly R Kalli; James Krempski; Ekram Gad; Mary L Disis; Keith L Knutson
The endogenous danger signal, crystalline uric acid, signals for enhanced antibody immunity.
Blood 2008;111(3):1472-9.
2007: Kimberly R Kalli
MORAb-003, a fully humanized monoclonal antibody against the folate receptor alpha, for the potential treatment of epithelial ovarian cancer.
Current opinion in investigational drugs (London, England : 2000) 2007;8(12):1067-73.
2007: Taufika Islam Williams; Kristina L Toups; Diana A Saggese; Kimberly R Kalli; William A Cliby; David C Muddiman
Epithelial ovarian cancer: disease etiology, treatment, detection, and investigational gene, metabolite, and protein biomarkers.
Journal of proteome research 2007;6(8):2936-62.
2006: Yuko Ogata; Carrie J Heppelmann; Carrie J Hepplmann; M Cristine Charlesworth; Benjamin J Madden; Melinda N Miller; Kimberly R Kalli; William A Cilby; H Robert Bergen; Diana A Saggese; David C Muddiman
Elevated levels of phosphorylated fibrinogen-alpha-isoforms and differential expression of other post-translationally modified proteins in the plasma of ovarian cancer patients.
Journal of proteome research 2006;5(12):3318-25.
2006: Keith L Knutson; Christopher J Krco; Courtney L Erskine; Karin Goodman; Linda E Kelemen; Peter J Wettstein; Philip S Low; Lynn C Hartmann; Kimberly R Kalli
T-cell immunity to the folate receptor alpha is prevalent in women with breast or ovarian cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(26):4254-61.
2006: Jeremy Chien; Giacomo Aletti; Alfonso Baldi; Vincenzo Catalano; Pietro Muretto; Gary L Keeney; Kimberly R Kalli; Julie Staub; Michael Ehrmann; William A Cliby; Yean Kit Lee; Keith C Bible; Lynn C Hartmann; Scott H Kaufmann; Viji Shridhar
Serine protease HtrA1 modulates chemotherapy-induced cytotoxicity.
The Journal of clinical investigation 2006;116(7):1994-2004.
2006: Paul Haluska; Joan M Carboni; David Loegering; Francis Y Lee; Mark Wittman; Mark G Saulnier; David B Frennesson; Kimberly R Kalli; Cheryl A Conover; Ricardo M Attar; Scott H Kaufmann; Marco Gottardis; Charles Erlichman
In vitro and in vivo antitumor effects of the dual insulin-like growth factor-I/insulin receptor inhibitor, BMS-554417.
Cancer research 2006;66(1):362-71.
2005: Peter J Tebben; Kimberly R Kalli; William A Cliby; Lynn C Hartmann; Joseph P Grande; Ravinder J Singh; Rajiv Kumar
Elevated fibroblast growth factor 23 in women with malignant ovarian tumors.
Mayo Clinic proceedings. Mayo Clinic 2005;80(6):745-51.
2005: Lynn C Hartmann; Karen H Lu; Gerald P Linette; William A Cliby; Kimberly R Kalli; David M Gershenson; Robert C Bast; James Stec; Natalia Iartchouk; David I Smith; Jeffrey S Ross; Sebastian Hoersch; Viji Shridhar; James Lillie; Scott H Kaufmann; Edwin A Clark; Andrew I Damokosh
Gene expression profiles predict early relapse in ovarian cancer after platinum-paclitaxel chemotherapy.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(6):2149-55.
2004: Kimberly R Kalli; Sarah V Bradley; Susanne Fuchshuber; Cheryl A Conover
Estrogen receptor-positive human epithelial ovarian carcinoma cells respond to the antitumor drug suramin with increased proliferation: possible insight into ER and epidermal growth factor signaling interactions in ovarian cancer.
Gynecologic oncology 2004;94(3):705-12.
2004: Kimberly R Kalli; Bing-Kun Chen; Laurie K Bale; Erica Gernand; Michael T Overgaard; Claus Oxvig; William A Cliby; Cheryl A Conover
Pregnancy-associated plasma protein-A (PAPP-A) expression and insulin-like growth factor binding protein-4 protease activity in normal and malignant ovarian surface epithelial cells.
International journal of cancer. Journal international du cancer 2004;110(5):633-40.
2003: Kimberly R Kalli; Kathryn E Devine; Myles C Cabot; Christina R Arnt; Michael P Heldebrant; Phyllis A Svingen; Charles Erlichman; Lynn C Hartmann; Cheryl A Conover; Scott H Kaufmann
Heterogeneous role of caspase-8 in fenretinide-induced apoptosis in epithelial ovarian carcinoma cell lines.
Molecular pharmacology 2003;64(6):1434-43.
2003: Janos L Tanyi; Yutaka Hasegawa; Ruth Lapushin; Andrew J Morris; Judith K Wolf; Andrew Berchuck; Karen Lu; David I Smith; Kimberly R Kalli; Lynn C Hartmann; Karen McCune; David Fishman; Russell R Broaddus; Kwai Wa Cheng; E Neely Atkinson; Jose-Miguel Yamal; Robert C Bast; Edward Felix; Robert A Newman; Gordon B Mills
Role of decreased levels of lipid phosphate phosphatase-1 in accumulation of lysophosphatidic acid in ovarian cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2003;9(10 Pt 1):3534-45.
2003: Kimberly R Kalli; Cheryl A Conover
The insulin-like growth factor/insulin system in epithelial ovarian cancer.
Frontiers in bioscience : a journal and virtual library 2003;8():d714-22.
2003: R J Walsh; S Matsuzaki; Tõnu Reinot; JM Hayes; Kimberly R Kalli; L C Hartmann; Gerald J Small
Single-cell nonphotochemical hole burning of ovarian surface epithelial carcinoma and normal cells.
Proceedings of the National Academy of Sciences of the United States of America 2003;100(4):1685-9.
2003: R J Walsh; Tõnu Reinot; JM Hayes; Kimberly R Kalli; L C Hartmann; Gerald J Small
Carcinoma and SV40-transfected normal ovarian surface epithelial cell comparison by nonphotochemical hole burning.
Biophysical journal 2003;84(2 Pt 1):1299-307.
2002: Kimberly R Kalli; Oluwole I Falowo; Laurie K Bale; Michael A Zschunke; Patrick C Roche; Cheryl A Conover
Functional insulin receptors on human epithelial ovarian carcinoma cells: implications for IGF-II mitogenic signaling.
Endocrinology 2002;143(9):3259-67.
2002: Kah-Whye Peng; Cynthia J Teneyck; Evanthia C Galanis; Kimberly R Kalli; Lynn C Hartmann; stephen russell
Intraperitoneal therapy of ovarian cancer using an engineered measles virus.
Cancer research 2002;62(16):4656-62.
2002: Stacy R Denison; Nicole A Becker; Matthew J Ferber; Leslie A Phillips; Kimberly R Kalli; John Lee; Jim Lillie; David I Smith; Viji Shridhar
Transcriptional profiling reveals that several common fragile-site genes are downregulated in ovarian cancer.
Genes, chromosomes & cancer 2002;34(4):406-15.
2001: Viji Shridhar; John Lee; Ajay Pandita; Stephen J Iturria; Rajeswari Avula; Julie Staub; M Morrissey; E Calhoun; A Sen; Kimberly R Kalli; Gary L Keeney; P Roche; William A Cliby; K Lu; Rosemarie Schmandt; Gordon B Mills; Robert C Bast; C David James; Fergus J. Couch; Lynn C Hartmann; Jim Lillie; David I Smith
Genetic analysis of early- versus late-stage ovarian tumors.
Cancer research 2001;61(15):5895-904.
2001: Viji Shridhar; K C Bible; Julie Staub; Rajeswari Avula; Y K Lee; Kimberly R Kalli; H Huang; Lynn C Hartmann; Scott H Kaufmann; David I Smith
Loss of expression of a new member of the DNAJ protein family confers resistance to chemotherapeutic agents used in the treatment of ovarian cancer.
Cancer research 2001;61(10):4258-65.
2000: Edward J Goetzl; Hans Lee; Hana Dolezalova; Kimberly R Kalli; Cheryl A Conover; Yu-Long Hu; T Azuma; Thomas P Stossel; Joel S Karliner; Robert B Jaffe
Mechanisms of lysolipid phosphate effects on cellular survival and proliferation.
Annals of the New York Academy of Sciences 2000;905():177-87.
1999: Edward J Goetzl; Hana Dolezalova; Yvonne Kong; Yu-Long Hu; Robert B Jaffe; Kimberly R Kalli; Cheryl A Conover
Distinctive expression and functions of the type 4 endothelial differentiation gene-encoded G protein-coupled receptor for lysophosphatidic acid in ovarian cancer.
Cancer research 1999;59(20):5370-5.
1998: Cheryl A Conover; Lynn C Hartmann; S Bradley; P Stalboerger; G G Klee; Kimberly R Kalli; R B Jenkins
Biological characterization of human epithelial ovarian carcinoma cells in primary culture: the insulin-like growth factor system.
Experimental cell research 1998;238(2):439-49.